Mana.bio is a company that combines advanced technologies in biology and medicine. The company focuses on drug delivery, machine learning, and software development.

Mana.bio

Mana.bio is an AI based drug delivery startup, creating a platform for Lipid Nanoparticle (LNP) development for oligonucleotide therapies including mRNA-based therapeutics, vaccines and gene therapy.



We're proud to announce that Mana has been accepted into the #NVIDIAInception program. 

We are honored to be part of a group of startups driving changes in #AI across industries and around the world. 
This program will provide us with several opportunities, including access to NVIDIA's latest technological resources and the chance to connect with peers who are working through similar challenges. 

This is yet another exciting milestone for us as we continue to grow and work to find improved RNA delivery options.

Our CEO Yogev Debbi recently published his thoughts on the importance of speaking the language of AI in Pharma and why the future of human health depends on it.

Dig into why the industry needs to do more engineering and less gambling when it comes to drug development and how to best re-frame the way lab work is measured in order to best embrace AI. 

See the full piece below

#pharma #AI #lab #data

💊 𝗡𝗮𝗻𝗼𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆-𝗯𝗮𝘀𝗲𝗱 𝗗𝗿𝘂𝗴 𝗗𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺𝘀: 𝟱 𝗦𝘁𝗮𝗿𝘁𝘂𝗽𝘀 𝘁𝗼 𝗪𝗮𝘁𝗰𝗵! 👀 

🔵 The growing use of nanotechnology in drug delivery is transforming healthcare by allowing for targeted, efficient, and controlled release of medications!

🔵 These young companies are great examples of startups leading the way in this transformation, developing state-of-the-art technologies that improve the precision and effectiveness of treatments!

🔵 From targeted cancer treatments to advanced gene therapies, these startups are laying the groundwork for a new era in medicine!

🔵 Take a look through the startups in our list:
💠 Aera Therapeutics
💠 Orion Therapeutics, Inc.
💠 NanoPhoria
💠 NanoVation Therapeutics™
💠 Mana.bio
----------------------------------------------
What startups can you add to the list?


Source: VentureRadar
#startup #drugdelivery #lipidnanoparticle #LNP #liposome #biotechnology #biopharmaindustry #nanotechnology

I was honored to present as a part of Biomed Israel 2024 last week discussing how to "Unlock Extra-Hepatic Delivery Using Machine Learning." Our work at Mana.bio, along with many other companies showed the potential for how #AI will continue to impact different aspects of #pharma including drug development, target discovery, diagnostics and more.

Overall the event showed just how many advancements have been made in genetic medicine therapeutics, delivery and clinical progress and it was heartening to see increased innovative science moving from academic research into newly functioning startups. We were thrilled to observe the potential in delivery of genetic medicine that will begin to disrupt so many therapeutic areas and we are excited to push forward as a community to leverage AI to unlock that promise.

Our CEO, Yogev Debbi will be speaking at Biomed Israel 2024 this week on May 21st 3-5pm local time. If you're registered, please consider attending and be sure to say hello.

We are excited to sponsor a Workshop at the Controlled Release Society conference this morning on The Application of AI to Drug Delivery. Co-sponsored with METiS Therapeutics and organized by Daniel Heller and Avi Schroeder, in the beautiful Bologna, Italy. Come and listen to so many terrific experts in this area.

#AI 
#drugdelivery
#LNP
#data

IPhone / Mobile Compatible

Viewport Meta

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

DNSSEC

Content Delivery Network

Global Site Tag

DoubleClick.Net

US Privacy User Signal Mechanism

Omri Amirav-Drory

Peter Nell

Roy Nevo

Co-Founder and CTO

Yogev Debbi

Co-Founder and CEO

Western US Startups (Top 10K)

West Coast Startups Founded in 2021

San Francisco Companies With Less Than $1B in Revenue (Top 10K)

Andreessen Horowitz Portfolio Companies

Mana.bio is an AI based drug delivery startup, focusing on gene therapy including DNA and RNA-based therapeutics, and vaccines.

Andreessen Horowitz

Seed Round - Mana.bio

San Francisco

California

United States

North America

Wanda Fish, Gutsy and Mana.bio Make Seed Raises

Israeli biotech startup Mana.bio launches AI-fueled programmable drug therapy

Mana.bio's platform uses machine learning to design lipid nanoparticle systems for delivering nucleic acid therapeutics and vaccines.

The company synthesizes lipid nanoparticle formulations rapidly using automated manufacturing pipelines.

Mana.bio evaluates lipid nanoparticles for efficacy, safety, and physicochemical properties through high-throughput screening.

Experimental results and publicly available data are used to continuously improve the machine learning models for designing LNPs.

Israel

Asia

United Kingdom

Europe

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 21, 2024 2:24 AM	5e93233b
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Dec 4, 2024 8:54 AM	bb51ba66
crunchbase profile	general	Dec 4, 2024 1:36 PM	779bbc2a
li profile	general	Aug 21, 2024 2:24 AM	fad917c1
translate crunchbase fundingrounds	general	Dec 4, 2024 2:00 PM	57791297
peers	general	Aug 21, 2024 2:24 AM	837efc9b
news basic	general	Aug 21, 2024 2:24 AM	78af45be
bundesanzeiger	filings
financials download nd	financials
private financials	financials

BIO:MANA

Mana.bio